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Abstract
Background: Numerous investigations have previously evaluated the association of interleukin (IL) 4 gene
polymorphisms and the risk of asthma, conferring inconsistent results. To resolve the incongruent outcomes yielded
from different single studies, we conducted the most up-to-date meta-analysis of IL4 gene −589C/T (rs2243250)
polymorphism and susceptibility to asthma.
Methods: A systematic literature search was performed in ISI web of science, Scopus, Medline/PubMed databases
prior to September 2020, and the pooled odds ratio (OR) and their corresponding 95% CI were calculated to
determine the association strength.
Results: Literature search led to retrieving of 49 publications (55 case-control studies) containing 9572 cases and
9881 controls. It was revealed that IL4 gene −589C/T polymorphism increased the risk of asthma across all genetic
models, including dominant model (OR = 1.22), recessive model (OR = 1.17), allelic model (OR = 1.21), and TT vs. CC
model (OR = 1.34), but not the CT vs. TT model. The subgroup analysis by age indicated that IL4 gene -589C/T
polymorphism was significantly associated with asthma risk in both pediatrics and adults. Additionally, the
subgroup analysis by ethnicity revealed significant association in Asian, American, and Europeans. Finally, subgroup
analysis by East Asian and non-East Asian populations indicated significant associations.
Conclusions: The current meta-analysis revealed that IL4 gene -589C/T polymorphism was a susceptibility risk in
both pediatrics and adults in the whole and different ethnic groups.
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Background
Asthma is one of the most common atopic disorders of
the respiratory tract, which results in wheezing, cough-
ing, breathlessness, and bronchial obstruction [1]. The
prevalence and incidence of asthma raised regularly and
it estimated more than 300 million persons of the world
are affected by this disease [2]. The main causes of
asthma are not completely clear. However, is has been
postulated that asthma is mediated by interactions be-
tween specific external stimulating factors, including
pollutants, viral and bacterial infections, allergens, to-
bacco smokes, etc., and genetics of the patients. Add-
itionally, increasing number of studies recommend that
genetic factors play a critical role in the etiology of
asthma by their interactions with the environmental ele-
ments [3, 4]. The heritability of asthma is estimated to
be 35 to 95% [5]. Numerous studies have examined the
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correlation between genetic variations of pro and anti-
inflammatory genes and susceptibility to asthma [6, 7].
In recent decades, single nucleotide polymorphisms
(SNP) have become one of the frequently studied models
of DNA variation in analyses of the association between
genetics and susceptibility to disease [8, 9].
The role of immunological factors especially cytokines
in modulating and controlling the inflammatory re-
sponse of the respiratory tracts is essential in the evolu-
tion, progression, and exacerbations of asthma [10].
Interleukin (IL)-4 is a key ingredient of the immune sys-
tem required in the regulation of response to an allergen
through controlling the isotype switching of antibody in
B lymphocytes to IgG and IgE class [11]. Elevated serum
levels of IgE are suggestive of allergic reactions and re-
semble a high level of IL-4 mRNA assembly [12]. More-
over, it acts as a growth factor to facilitate the
differentiation of T helper (Th) 2 cells and mast cells.
These characteristics of IL-4 accentuate on the crucial
roles of cytokines in the pathogenesis asthma [13, 14].
Additionally, IL4 gene polymorphisms, like promoter re-
gion (C + 33 T) SNP [15], and 3017 G/T SNP in intron 2
[16], have been associated with IgE levels, which might
be involved in the pathogenesis of asthma.
The IL4 gene is located on chromosome 5q31 [17].
The -589C/T (rs2243250) polymorphism has been rec-
ognized on upstream of the transcription initiation site
[18]. It has been demonstrated that the binding of a
transcription factor is enhanced by the appearance of
the polymorphic T allele that may result in an overex-
pression of the IL4 gene and, thus, raising the power of
any immunological response that dependents on IL-4
[19]. To date, many studies have examined the associ-
ation between IL4 gene -589 C/T polymorphisms and
the risk of asthma, but their outcomes have not been
consistent. Therefore, we performed this meta-analysis
to analyze the relationship between the -589C/T poly-
morphisms and susceptibility to asthma.
Methods
This study conducted in accordance with the Preferred
Reporting Items for Systematic reviews and Meta-Ana-
lyses (PRISMA) statement including; literature review,
study selection, inclusion and exclusion criteria, data ex-
traction and quality assessment, and statistical analysis
[20]. No ethics committee confirmation was necessary
for this meta-analysis, which does not contain any stud-
ies with human participants or animals performed by
any of the authors.
Literature review
A comprehensive search was performed in the ISI web
of science, Scopus, Medline/PubMed databases to re-
trieve published articles prior to September 2020. The
following main key words and Medical Subject Headings
(Mesh) were searched: (“asthma” [Mesh] OR “asth-
matic”) AND (“interleukin-4” OR “IL-4” OR
“rs2243250”) AND (“single nucleotide polymorphism”
OR “SNP” OR “polymorphisms” OR “mutation” OR
“variation”). No restrictions were placed on language,
sample size, population or publication date.
Study selection
The retrieved publications by primary literature search
were imported into Endnote X8 software. The duplicate
studies were removed and title and abstract of remain
studies were reviewed by two investigators. Full-text
verification was performed if we could not categorize
studies based on title and abstract. Any disagreements
during study selection was discussed and resolved by
consensus.
Inclusion and exclusion criteria
The following inclusion criteria were used to distinguish
eligible studies: i) studies with distinct case and control
group evaluating the association between IL-4 C589T
polymorphism and susceptibility to asthma; ii) studies
with calculable or extractable data for odds ratio (OR)
and 95% confidence intervals (CIs); iii) studies with suffi-
cient data for alleles and genotypes in case and control
group. The duplicates, reviews, book chapters, and
meta-analysis were excluded. The application of these
criteria results in 49 qualified studies for the meta-
analysis.
Data extraction and quality assessment
Two of our authors independently and according to an
extraction checklist extracted the following data: the first
author, journal and year of publication, country of ori-
gin, ethnicity, number of subjects in the case and the
control groups for each gender, mean or range of age,
genotyping method, genotype counts in the case and the
control group. The quality of each study was assessed
using the Newcastle-Ottawa Scale (NOS) criteria [21].
Studies with scores 0–3, 4–6 or 7–9 were low, moderate
or high-quality, respectively.
Statistical analysis
Statistical analyses were carried out using STATA (ver-
sion 14.0; Stata Corporation, College Station, TX) and
SPSS (version 23.0; SPSS, Inc. Chicago, IL). The strength
of association between polymorphism and asthma sus-
ceptibility was estimated by odd ratios (ORs) and 95%
confidence intervals (CIs) for the dominant model, re-
cessive model, allele contrasts, and additive comparison.
Heterogeneity among included studies was measured via
Q statistics (P value< 0.1 considered statistically signifi-
cant) and I2-test (I2 values of 25, 50 and 75% were
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described as low, moderate, and high heterogeneity, re-
spectively). In the presence of heterogeneity random ef-
fect model (REM) was used, however fixed effect model
(FEM) was applied in homogeneous condition [22, 23].
In order to assessed the predefined sources of hetero-
geneity among included studies, subgroup analysis and
meta-regression analysis based on year of population,
the continent of the study population, and genotyping
method were performed. The genotypic frequency distri-
bution in the controls was checked for consistency of
the Hardy– Weinberg equilibrium (HWE). Furthermore,
publication bias was computed by the Begg’s and Egger’s
test and visual examination of the funnel plot (P value<
0.05 considered statistically significant) [24, 25]. Add-
itionally, to calculate overall effect size in absence of
each study, a sensitivity analysis was conducted.
Results
Search results and characteristics of the selected studies
Our primary search retrieved 2121 potential articles. After
removing of duplicate articles (n = 301), 1820 articles re-
main for abstract and full-text screening. Of 1820 articles,
1612 were excluded base on title and abstract and 159 ar-
ticles based on full-text reading. Ultimately 49 publica-
tions with 9579 cases and 9881 controls met the inclusion
criteria and their data were extracted for meta-analysis.
Among these 49 publications, four of them, including
Basehore et al. [16], Donfack et al. [26], Zhang et al. [27],
and Baye et al. [28] examined two or three different popu-
lations with separate case and control; therefore, we as-
sumed them as 9 case-control studies collectively (55
studies). The detailed information on study selection
process is illustrated in Fig. 1, Tables 1, and 2.
Meta-analysis of IL-4 SNP (C-589 T) and the risk of asthma
Overall, 55 studies with 9572 cases and 9881 controls in-
cluded in quantitative analysis of the association between
IL-4 gene -589C/T polymorphism and the risk of
asthma. Of those, 11 articles were conducted in Euro-
pean countries [29, 31, 33, 38–41, 55, 63, 64, 69], 32 arti-
cles were in Asian countries [27, 30, 32, 34–37, 43–46,
49, 50, 53, 54, 56–62, 65, 66, 68, 70–73], 10 articles in
American countries [16, 26, 28, 42, 48, 52] and one art-
icle in each Algeria [67] and Australia country [51]. The
analysis of overall population revealed the significant
positive association between IL4 gene -589C/T poly-
morphism and the risk of asthma across all genetic
models; including dominant model (OR = 1.22, 95% CI =
1.04–1.44, P = 0.01, REM), recessive model (OR = 1.17,
95% CI = 1.08–1.27, P < 0.001, FEM), allelic model (OR =
1.21, 95% CI = 1.09–1.33, P < 0.001, REM), and TT vs.
CC model (OR = 1.34, 95% CI = 1.18–1.52, P < 0.001,
FEM), except CT vs. TT model (OR = 1.13, 95% CI =
0.95–1.34, P = 0.17, REM) (Fig. 2). Additionally, along
with subgroup analysis based on age we stratified the
analysis by ethnicity in three conditions.
Subgroup analysis by age
We stratified eligible articles into three groups including:
pediatrics (16 articles), adults (21 articles) and mixed
(cover both range;18 articles). The results highlighted a
predisposing role of IL4 gene -589C/T polymorphism
for the asthma risk in pediatrics and adults under all
genotype models. However, no significant association
was detected in mixed group (Table 3, Fig. 3).
Subgroup analysis by ethnicity 1 (continent)
In this subgroup we categorized studies by their contin-
ent: including Asia (32 articles), Europe (11 articles),
America (10 articles), Africa (1 article), and Oceania (1
article). Since there was only one study for each one of
the African and Australian population, these studies
were excluded from the analysis. The results indicated
that presence of IL4 gene -589C/T SNP in Asian popula-
tion increased susceptibility of asthma across all geno-
type models except dominant model (OR = 1.15, 95%
CI = 0.84–1.56, P = 0. 39, REM) and CT vs. CC model
(OR = 1, 95% CI = 0.70–1.42, P = 0. 97, REM). Moreover,
in contrast with effect of IL4 gene -589C/T SNP on the
risk of asthma in American populations, a significant
positive association was detected in European population
thorough dominant model (OR = 1.46, 95% CI = 1.15–
1.85, P < 0.001, REM), allelic model (OR = 1.34, 95% CI =
1.12–1.61, P < 0.001, REM), TT vs. CC model (OR =
1.53, 95% CI = 1.10–2.14, P = 0.01, FEM), and CT vs.CC
model (OR = 1.44, 95% CI = 1.13–1.83, P < 0.001, REM)
(Table 3, Fig. 3).
Subgroup analysis by ethnicity 2 (east and non-east
Asian)
The subgroup analysis according to East Asian (20 articles)
and non-East Asian (35 articles) title revealed the significant
association between IL4 gene -589C/T polymorphism and
the risk of asthma across in all genotype models of East
Asians and three genotype models of non-East Asian in-
cluding; recessive model (OR = 1.25, 95% CI = 1.08–1.45,
P < 0.001, FEM), allelic model (OR = 1.15, 95% CI = 1–1.32,
P = 0.04, REM), TT vs. CC model (OR = 1.34, 95% CI =
1.12–1.61, P < 0.001, FEM) (Table 3, Fig. 4).
Subgroup analysis by ethnicity 3
Finally, subgroup analysis of eligible articles accord-
ing ethnicity including Caucasians (41 articles),
African-Americans (9 articles), and Arabs (5 articles)
showed that there was no significant association be-
tween IL4 gene -589C/T SNP and asthma risk in
Arab population. Also, except recessive model (OR =
1.18, 95% CI = 0.98–1.43, P = 0.07, FEM) other
Kousha et al. BMC Immunology           (2020) 21:55 Page 3 of 16
genotype models in African-American population
were significant including dominant model (OR =
1.34, 95% CI = 1.07–1.67, P = 0.01, FEM), allelic
model (OR = 1.25, 95% CI = 1.04–1.50, P = 0.01,
REM), TT vs. CC model (OR = 1.37, 95% CI = 1.04–
1.80, P = 0.02, FEM), and CT vs. CC model (OR =
1.30, 95% CI = 1.06–1.58, P = 0.01, FEM). Conversely,
all genotype models were significant in Caucasians
and presence of IL4 gene -589C/T SNP increase risk
of asthma (Table 3, Fig. 4).
Meta-regression analyses
Meta-regression analyses were performed to explore po-
tential sources of heterogeneity among included studies
(Table 4). The findings indicated that none of the ex-
pected heterogeneity parameter were the source of het-
erogeneity (Fig. 5).
Publication bias
To check existence of publication, Egger’s linear regres-
sion and Begg’s funnel plot test were used. The shape of
Fig. 1 Flow diagram of study selection process
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Table 1 Characteristics of studies included in meta-analysis of overall asthma
Study author Year Country Ethnicity 1
(Continent)
Ethnicity
2
Ethnicity 3 Age
group
Total cases/
control
Genotyping method Quality
Score
Walley et al. [29] 1996 UK Europe non East-
Asian
Caucasian Pediatric 124 / 59 PCR-RFLP 6
Hijazi et al. [30] 2000 Kuwait Asia non East-
Asian
Arab Mixed 84 / 100 PCR-RFLP 6
Sandford et al. [31] 2000 New
Zealand
Europe non East-
Asian
Caucasian Adult 233 / 143 PCR-RFLP 7
Takabayashi et al. [32] 2000 Japan Asia East-Asian Caucasian Pediatric 100 / 100 PCR-RFLP 6
Hakonarson et al. [33] 2001 Iceland Europe non East-
Asian
Caucasian Mixed 94 / 94 PCR 6
Cui et al. [34] 2003 China Asia East-Asian Caucasian Mixed 241 / 175 PCR-RFLP 7
Basehore et al. (i) [16] 2004 USA America non East-
Asian
African
American
Adult 233 / 245 PCR 7
Basehore et al. (ii) [16] 2004 USA America non East-
Asian
African
American
Adult 168 / 269 PCR 7
Basehore et al. (iii)
[16]
2004 USA America non East-
Asian
African
American
Adult 116 / 130 PCR 6
Lee et al. [35] 2004 Korea Asia East-Asian Caucasian Pediatric 254 / 100 PCR-RFLP 6
Park et al. [36] 2004 Korea Asia East-Asian Caucasian Mixed 532 / 170 SNaPshot 8
Wang et al. [37] 2004 China Asia East-Asian Caucasian Adult 93 / 62 PCR-RFLP 6
Adjers et al. [38] 2004 Finland Europe non East-
Asian
Caucasian Adult 243 / 401 PCR-RFLP 7
Donfack et al. (i) [26] 2005 USA America non East-
Asian
African
American
Mixed 126/ 205 LAS 6
Donfack et al. (ii) [26] 2005 USA America non East-
Asian
African
American
Mixed 205 / 183 LAS 7
Zhang et al. (i) [27] 2005 China Asia East-Asian Caucasian Adult 152 / 157 PCR-RFLP 6
Zhang et al. (ii) [27] 2005 Malaysia Asia East-Asian Caucasian Adult 76 / 100 PCR-RFLP 6
Zhang et al. (iii) [27] 2005 India Asia non East-
Asian
Caucasian Adult 87 / 103 PCR-RFLP 6
Gervaziev et al. [39] 2006 Russia Europe non East-
Asian
Caucasian Adult 109 / 68 PCR-RFLP 6
Schubert et al. [40] 2006 Germany Europe non East-
Asian
Caucasian Pediatric 231 / 270 PCR-RFLP 7
Kabesch et al. [41] 2006 Germany Europe non East-
Asian
Caucasian Pediatric 73 / 773 PCR-RFLP 6
Battle et al. [42] 2007 USA America non East-
Asian
African
American
Mixed 255 / 175 PCR-RFLP 6
Hosseini-Farahabadi
et al. [43]
2007 Iran Asia non East-
Asian
Caucasian Adult 30 / 50 PCR-RFLP 5
Kamali-Sarvestani et
al. [44]
2007 Iran Asia non East-
Asian
Caucasian Adult 149 / 112 PCR-RFLP 6
Chiang et al. [45] 2007 China Asia East-Asian Caucasian Adult 167 / 111 PCR-RFLP 6
Mak et al. [46] 2007 China Asia East-Asian Caucasian Adult 289 / 292 PCR-RFLP 7
Attab et al. [47] 2008 Jordan Asia non East-
Asian
Arab Pediatric 40 / 40 PCR-RFLP 5
De Faria et al. [48] 2008 Brazil America non East-
Asian
Caucasian Pediatric 88 / 202 PCR-RFLP 6
Jiang et al. [49] 2009 China Asia East-Asian Caucasian Adult 13 / 13 PCR-RFLP 5
Amirzargar et al. [50] 2009 Iran Asia non East-
Asian
Caucasian Mixed 59 / 139 PCR-RFLP 6
Daley et al. [51] 2009 Australia Oceania non East-
Asian
Caucasian Mixed 644 / 751 Illumina Bead array
system
8
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funnel plot did not disclose obvious asymmetry under all
genotype model of the IL4 gene -589C/T polymorphism
(Fig. 6).
Sensitivity analysis
The impact of individual study on pooled OR was evalu-
ated by sequential omission of each studies. The result
showed that no individual study significantly affected the
pooled ORs under all genotype models of the IL4 gene
-589C/T polymorphism (Fig. 7).
Discussion
To date, several individual case-control replication
studies have attempted to divulge the association of
IL4 gene -589C/T polymorphism and risk of asthma.
Due to some differences, however, these disperse
investigation demonstrated incongruous reports. The
differences in the race of study subjects, diversity in
the diagnostic criteria of the patients, limited sample
sizes may be the cause of such inconsistent results
[74]. On the other hand, meta-analysis is a tool that
has the potential to solve the problem of
Table 1 Characteristics of studies included in meta-analysis of overall asthma (Continued)
Study author Year Country Ethnicity 1
(Continent)
Ethnicity
2
Ethnicity 3 Age
group
Total cases/
control
Genotyping method Quality
Score
Haller et al. [52] 2009 USA America non East-
Asian
African
American
Adult 72 / 70 PCR-RFLP 6
Rad et al. [53] 2010 Iran Asia non East-
Asian
Caucasian Adult 64 / 65 PCR-RFLP 6
Wu et al. [54] 2010 China Asia East-Asian Caucasian Pediatric 252 / 227 PCR-RFLP 7
Beghe et al. [55] 2010 UK and
Italy
Europe non East-
Asian
Caucasian Mixed 299 / 176 PCR-RFLP 7
Bijanzadeh et al. [56] 2010 India Asia non East-
Asian
Caucasian Mixed 100 / 50 PCR-RFLP 6
Fance et al. [57] 2010 China Asia East-Asian Caucasian Adult 62 / 30 PCR-RFLP 6
Baye et al. (i) [28] 2011 USA America non East-
Asian
African
American
Pediatric 413 / 298 Illumina GoldenGate
Assay system
7
Baye et al. (ii) [28] 2011 USA America non East-
Asian
African
American
Pediatric 315 / 51 Illumina GoldenGate
Assay system
6
Daneshmandi et al.
[58]
2011 Iran Asia non East-
Asian
Caucasian Adult 81 / 124 PCR-RFLP 7
Huang et al. [59] 2011 China Asia East-Asian Caucasian Pediatric 100 / 122 PCR-RFLP 6
Hwang et al. [60] 2012 China Asia East-Asian Caucasian Pediatric 188 / 376 PCR-RFLP 7
Chiang et al. [61] 2012 China Asia East-Asian Caucasian Adult 452 / 106 PCR-RFLP 6
Micheal et al. [62] 2013 Pakistan Asia non East-
Asian
Caucasian Mixed 108 / 120 PCR-RFLP 6
Ricciardolo et al. [63] 2013 Italy Europe non East-
Asian
Caucasian Mixed 57 / 124 PCR-SSP 6
Smolnikova et al. [64] 2013 Russia Europe non East-
Asian
Caucasian Mixed 64 / 50 PCR-RFLP 6
Li et al. [65] 2014 China Asia East-Asian Caucasian Pediatric 491 / 503 PCR-LDR 7
Wang et al. [66] 2015 China Asia East-Asian Caucasian Mixed 392 / 849 Mass array 7
Dahmani et al. [67] 2016 Algeria Africa non East-
Asian
Arab Adult 44 / 19 PCR-RFLP 6
Li et al. [68] 2016 China Asia East-Asian Caucasian Pediatric 317 /351 PCR and Sequencing 7
Narozna et al. [69] 2016 Poland Europe non East-
Asian
Caucasian Mixed 177 / 189 Taq Man 7
Zhang et al. [68] 2016 China Asia East-Asian Caucasian Pediatric 38 / 35 PCR and Sequencing 6
Hussein et al. [70] 2017 Iraq Asia non East-
Asian
Arab Mixed 48 / 25 ARMS-PCR 6
Abood et al. [71] 2018 Iraq Asia non East-
Asian
Arab Mixed 100 / 100 AS-PCR 6
Zhang et al. [72] 2019 China Asia East-Asian Caucasian Pediatric 37 / 29 PCR and Sequencing 5
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Table 2 Distribution of genotype and allele among asthma patients and controls
Study author Asthma cases Healthy control P-
HWE
MAF
CC CT TT C T CC CT TT C T
Walley et al. [29] 56 55 13 167 81 31 23 5 85 33 0/8 0/72
Hijazi et al. [30] 5 25 54 35 133 9 31 60 49 151 0/1 0/245
Sandford et al. [31] 146 78 9 370 96 100 41 2 241 45 0/33 0/842
Takabayashi et al. [32] 6 43 51 55 145 10 39 51 59 141 0/53 0/295
Hakonarson et al. [33] 73 20 1 166 22 67 25 2 159 29 0/85 0/845
Cui et al. [34] 11 89 141 111 371 9 52 114 70 280 0/34 0/2
Basehore et al. (i) [16] 153 72 8 378 88 181 59 5 421 69 0/94 0/859
Basehore et al. (ii) [16] 22 77 69 121 215 29 119 121 177 361 0/97 0/329
Basehore et al. (iii) [16] 43 55 18 141 91 55 59 16 169 91 0/97 0/65
Lee et al. [35] 9 77 168 95 413 3 29 68 35 165 0/96 0/175
Park et al. [36] 19 164 349 202 862 7 54 109 68 272 0/92 0/2
Wang et al. [37] 29 42 22 100 86 21 26 15 68 56 0/22 0/548
Adjers et al. [38] 106 103 34 315 171 189 164 48 542 260 0/18 0/675
Donfack et al. (i) [26] 85 34 7 204 48 144 55 6 343 67 0/78 0/836
Donfack et al. (ii) [26] 25 82 98 132 278 24 82 77 130 236 0/76 0/355
Zhang et al. (i) [27] 4 47 101 55 249 3 45 109 51 263 0/5 0/162
Zhang et al. (ii) [27] 11 35 30 57 95 16 43 41 75 125 0/4 0/375
Zhang et al. (iii) [27] 50 31 6 131 43 66 30 7 162 44 0/17 0/786
Gervaziev et al. [39] 16 75 18 107 111 18 43 7 79 57 0/01 0/58
Schubert et al. [40] 143 78 10 364 98 189 74 7 452 88 0/93 0/837
Kabesch et al. [41] 42 29 2 113 33 564 188 21 1316 230 0/26 0/851
Battle et al. [42] 28 113 114 169 341 19 77 79 115 235 0/97 0/328
Hosseini-Farahabadi et al. [43] 17 8 5 42 18 38 12 0 88 12 0/33 0/88
Kamali-Sarvestani et al. [44] 139 6 4 284 14 93 18 1 204 20 0/9 0/91
Chiang et al. [45] 1 19 147 21 313 7 34 70 48 174 0/31 0/216
Mak et al. [46] 15 95 179 125 453 19 87 186 125 459 0/05 0/214
Attab et al. [47] 31 9 0 71 9 33 7 0 73 7 0/54 0/912
De Faria et al. [48] 38 41 9 117 59 67 108 27 242 162 0/1 0/599
Jiang et al. [49] 0 8 5 8 18 1 9 3 11 15 0/13 0/423
Amirzargar et al. [50] 0 59 0 59 59 10 129 0 149 129 < 0.001 0/535
Daley et al. [51] 476 155 13 1107 181 549 186 16 1284 218 0/95 0/854
Haller et al. [52] 6 30 36 42 102 7 31 32 45 95 0/89 0/321
Rad et al. [53] 46 18 0 110 18 42 23 0 107 23 0/08 0/823
Wu et al. [54] 6 83 163 95 409 11 84 132 106 348 0/61 0/233
Beghe et al. [55] 232 63 4 527 71 136 37 3 309 43 0/79 0/877
Bijanzadeh et al. [56] 92 4 4 188 12 48 1 1 97 3 < 0.001 0/97
Fance et al. [57] 38 13 11 89 35 27 1 2 55 5 < 0.001 0/916
Baye et al. (i) [28] 267 130 16 664 162 233 61 4 527 69 0/99 0/884
Baye et al. (ii) [28] 35 140 140 210 420 12 25 14 49 53 0/89 0/48
Daneshmandi et al. [58] 63 15 3 141 21 94 26 4 214 34 0/2 0/862
Huang et al. [59] 1 19 80 21 179 4 43 75 51 193 0/46 0/209
Hwang et al. [60] 1 51 136 53 323 12 89 275 113 639 0/15 0/15
Chiang et al. [61] 13 110 329 136 768 7 34 65 48 164 0/38 0/226
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inconsistency by removing the confining issues of in-
sufficient statistical power in the individual studies.
Therefore, to resolve the mentioned confining factors
about the IL4 gene -589C/T polymorphism, the
present most up-to-date meta-analysis was conducted
to determine a bona fide estimation of the association
between IL4 gene -589C/T polymorphism and suscep-
tibility to asthma. Our analysis indicated that this
SNP was associated with increased risk of asthma in
the overall population as well as during subgroup
analysis by age groups and ethnicity/continent.
Asthma is a complicated pulmonary disease, character-
ized by airway hyperresponsiveness, airway inflamma-
tion, and airway remodeling [75, 76]. During asthma,
there is a hyperactivity of Th2 responses, in which the
cytokines of the type 2 immunity, such as IL-4, IL-5, and
Table 2 Distribution of genotype and allele among asthma patients and controls (Continued)
Study author Asthma cases Healthy control P-
HWE
MAF
CC CT TT C T CC CT TT C T
Micheal et al. [62] 26 63 19 115 101 31 84 5 146 94 < 0.001 0/608
Ricciardolo et al. [63] 35 19 3 89 25 109 12 3 230 18 < 0.001 0/927
Smolnikova et al. [64] 36 28 0 100 28 39 11 0 89 11 0/38 0/89
Li et al. [65] 17 150 324 184 798 21 144 338 186 820 0/26 0/184
Wang et al. [66] 50 177 165 277 507 104 412 333 620 1078 0/17 0/365
Dahmani et al. [67] 13 19 12 45 43 6 11 2 23 15 0/35 0/605
Li et al. [68] 112 0 205 224 410 138 0 213 276 426 < 0.001 0/393
Narozna et al. [69] 117 55 5 289 65 133 53 3 319 59 0/37 0/843
Zhang et al. [68] 8 11 19 27 49 17 13 5 47 23 0/34 0/671
Hussein et al. [70] 42 5 1 89 7 8 13 4 29 21 0/73 0/58
Abood et al. [71] 66 17 17 149 51 7 90 3 104 96 < 0.001 0/52
Zhang et al. [72] 7 13 17 27 47 11 15 3 37 21 0/51 0/637
P-HWE p-value for Hardy–Weinberg equilibrium, MAF minor allele frequency of control group
Fig. 2 Pooled OR and 95% CI of individual studies and pooled data for the association between Il-4 C589T polymorphism and asthma risk in; a
allelic model, b recessive Model
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Table 3 Main results of pooled ORs in meta-analysis of IL-4 gene polymorphisms in asthmatic patients
Subgroup Sample size Test of association Test of
heterogeneity
Test of publication
bias (Begg’s test)
Test of publication
bias (Egger’s test)
Genetic model Case/Control OR 95% CI (p-value) I2 (%) P z P t P
Overall Dominant model 9579 / 9881 1.22 1.04–1.44 (0.01) 69.7 < 0.001 - 1.33 0.24 - 1.17 0.39
Recessive model 9579 / 9881 1.17 1.08–1.27 (< 0.001) 48.5 < 0.001 −1.38 0.16 −0.60 0.55
Allelic model 9579 / 9881 1.21 1.09–1.33 (< 0.001) 71.1 < 0.001 − 1.05 0.41 −1.82 0.07
TT vs. CC 9579 / 9881 1.34 1.18–1.52 (< 0.001) 30.5 0.02 −1.25 0.24 −1.90 0.65
CT vs. CC 9579 / 9881 1.13 0.95–1.34 (0.17) 68.7 < 0.001 −2.06 0.33 −1.73 0.09
Age groups
Pediatrics Dominant model 3061 / 3536 1.54 1.24–1.92 (< 0.001) 41 0.04 − 1.93 0.05 −1.63 0.23
Recessive model 3061 / 3536 1.20 1.05–1.37 (< 0.001) 58.3 < 0.001 −0.36 0.71 −1.14 0.27
Allelic model 3061 / 3536 1.37 1.16–1.63 (< 0.001) 68 < 0.001 −1.53 0.12 − 1.99 0.06
TT vs. CC 3061 / 3536 1.51 1.22–1.87 (< 0.001) 51.6 0.01 −1.44 0.15 −1.47 0.24
CT vs. CC 3061 / 3536 1.49 1.23–1.81 (< 0.001) 10.6 0.33 −1.92 0.05 −1.22 0.42
Adults Dominant model 2933 / 2670 1.23 1.01–1.51 (0.04) 35.2 0.066 −2.10 0.03 −1.86 0.08
Recessive model 2933 / 2670 1.21 1.04–1.40 (0.01) 46 0.01 −0.91 0.36 −0.71 0.48
Allelic model 2933 / 2670 1.24 1.05–1.47 (< 0.001) 63.8 < 0.001 −0.97 0.33 −1.45 0.16
TT vs. CC 2933 / 2670 1.37 1.09–1.72 (< 0.001) 5 0.39 −1.01 0.47 −1.77 0.19
CT vs. CC 2933 / 2670 1.15 0.96–1.39 (0.13) 23 0.17 −2.13 0.03 −1.56 0.13
Mixed Dominant model 3585 / 3675 0.92 0.65–1.32 (0.65) 83.6 < 0.001 −0.09 0.92 − 1.05 0.31
Recessive model 3585 / 3675 1.12 0.97–1.28 (0.11) 45.4 0.02 −0.41 0.68 0.39 0.70
Allelic model 3585 / 3675 1.03 0.85–1.24 (0.78) 76.3 < 0.001 −0.72 0.47 0.02 0.98
TT vs. CC 3585 / 3675 1.14 0.91–1.42 (0.24) 20.8 0.21 −0.18 0.85 −0.28 0.87
CT vs. CC 3585 / 3675 0.87 0.59–1.28 (0.48) 84.9 < 0.001 0 1 −1.11 0.28
Ethnicity-1 (Continent)
Asia Dominant model 5196 / 4936 1.15 0.84–1.56 (0.39) 75.6 < 0.001 −1.86 0.06 −1.44 0.20
Recessive model 5196 / 4936 1.16 1.06–1.28 (< 0.001) 65 < 0.001 −1.62 0.10 −0.60 0.55
Allelic model 5196 / 4936 1.17 1–1.37 (0.04) 76.7 < 0.001 −1.72 0.08 −1.04 0.30
TT vs. CC 5196 / 4936 1.34 1.13–1.58 (< 0.001) 42.7 0.01 −1.48 0.13 −1.15 0.40
CT vs. CC 5196 / 4936 1 0.70–1.42 (0.97) 75.1 < 0.001 −2 0.04 −1.42 0.20
Europe Dominant model 1704 / 2347 1.46 1.15–1.85 (< 0.001) 56.9 0.01 0 1 −0.70 0.49
Recessive model 1704 / 2347 1.35 0.98–1.86 (0.06) 0 0.94 − 1.58 0.11 −1.91 0.08
Allelic model 1704 / 2347 1.34 1.12–1.61 (< 0.001) 51 0.02 −1.03 0.30 −1.50 0.16
TT vs. CC 1704 / 2347 1.53 1.10–2.14 (0.01) 0 0.80 0.16 0.87 −0.87 0.40
CT vs. CC 1704 / 2347 1.44 1.13–1.83 (< 0.001) 55.6 0.01 0.78 0.43 0.33 0.74
America Dominant model 1991 / 1828 1.22 0.95–1.58 (0.11) 54.5 0.01 −1.33 0.27 −2.05 0.07
Recessive model 1991 / 1828 1.15 0.96–1.39 (0.12) 24.3 0.22 −1.34 0.18 0.99 0.35
Allelic model 1991 / 1828 1.19 0.99–1.44 (0.06) 64.8 < 0.001 − 0.98 0.32 −0.48 0.64
TT vs. CC 1991 / 1828 1.27 0.98–1.64 (0.07) 43.7 0.06 − 1.52 0.12 −1.91 0.09
CT vs. CC 1991 / 1828 1.18 0.94–1.48 (0.15) 39.3 0.09 −1.52 0.12 −1.94 0.08
Ethnicity-2
East-Asian Dominant model 4246 / 3908 1.43 1.14–1.79 (< 0.001) 26.3 0.14 −1.08 0.28 1.53 0.29
Recessive model 4246 / 3908 1.14 1.03–1.26 (< 0.001) 66.6 < 0.001 −1.02 0.27 −1.51 0.36
Allelic model 4246 / 3908 1.29 1.10–1.52 (< 0.001) 72 < 0.001 −1.79 0. 58 −3.10 0.06
TT vs. CC 4246 / 3908 1.33 1.11–1.59 (< 0.001) 41.8 0.02 −1.27 0.29 −1.39 0.31
CT vs. CC 4246 / 3908 1.24 1.00–1.53 (0.04) 0 0.74 −1.89 0.68 −1.71 0.10
Non-East-Asian Dominant model 5333 / 5973 1.10 0.90–1.36 (0.35) 77.4 < 0.001 −0.80 0.42 −1.18 0.35
Recessive model 5333 / 5973 1.25 1.08–1.45 (< 0.001) 21.9 0.14 0.59 0.55 0.73 0.47
Allelic model 5333 / 5973 1.15 1–1.32 (0.04) 71.5 < 0.001 −1.05 0.48 −1.82 0.07
TT vs. CC 5333 / 5973 1.34 1.12–1.61 (< 0.001) 24 0.11 −0.37 0.70 −1.04 0.30
CT vs. CC 5333 / 5973 1.03 0.83–1.28 (0.78) 77.9 < 0.001 −1.16 0.24 −1.93 0.06
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Table 3 Main results of pooled ORs in meta-analysis of IL-4 gene polymorphisms in asthmatic patients (Continued)
Subgroup Sample size Test of association Test of
heterogeneity
Test of publication
bias (Begg’s test)
Test of publication
bias (Egger’s test)
Genetic model Case/Control OR 95% CI (p-value) I2 (%) P z P t P
Ethnicity 3
Caucasian Dominant model 7360 / 7971 1.30 1.12–1.51 (< 0.001) 49.2 < 0.001 −1.04 0.48 −1.51 0.18
Recessive model 7360 / 7971 1.16 1.06–1.27 (< 0.001) 49.7 < 0.001 −1.31 0.24 −2.77 0.09
Allelic model 7360 / 7971 1.25 1.12–1.39 (< 0.001) 65 < 0.001 1.40 0.17 −1.12 0.38
TT vs. CC 7360 / 7971 1.34 1.16–1.56 (< 0.001) 24.9 0.09 −1.52 0.16 −1.34 0.29
CT vs. CC 7360 / 7971 1.22 1.05–1.42 (< 0.001) 39.6 < 0.001 −1.54 0.12 −1.80 0.08
Arab Dominant model 316 / 284 0.36 0.07–1.88 (0.22) 91.5 < 0.001 0.68 0.49 −0.17 0.83
Recessive model 316 / 284 1.53 0.27–1.48 (0.09) 87.4 < 0.001 0 1 −1.67 0.19
Allelic model 316 / 284 0.63 0.67–3.68 (0.29) 85.4 < 0.001 0.49 0.62 −0.11 0.92
TT vs. CC 316 / 284 0.93 0.43–1.99 (0.85) 66.6 0.02 0.68 0.49 1.25 0.33
CT vs. CC 316 / 284 0.29 0.05–1.84 (0.19) 92.3 < 0.001 0 1 −0.71 0.55
African-American Dominant model 1903 / 1626 1.34 1.07–1.67 (0.01) 35.3 0.13 −1.67 0.09 1.97 0.27
Recessive model 1903 / 1626 1.18 0.98–1.43 (0.07) 24.7 0.22 0.63 0.53 1.11 0.30
Allelic model 1903 / 1626 1.25 1.04–1.50 (0.01) 58.9 0.01 −1.46 0.14 −0.81 0.44
TT vs. CC 1903 / 1626 1.37 1.04–1.80 (0.02) 36.2 0.12 −1.67 0.09 −1.44 0.40
CT vs. CC 1903 / 1626 1.30 1.06–1.58 (0.01) 13.9 0.31 −1.67 0.09 −1.46 0.41
Fig. 3 Pooled odds ratio and 95% confidence interval of individual studies and pooled data for the association between IL-4 C589T
polymorphism and asthma risk in different subgroups for; a dominant model [age subgroup], b dominant model [continent]
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Fig. 4 Pooled odds ratio and 95% confidence interval of individual studies and pooled data for the association between IL-4 C589T
polymorphism and asthma risk in different subgroups for; a dominant model [East and non-East Asian], b dominant model [ethnicity]
Table 4 Meta-regression analyses of potential source of heterogeneity
Heterogeneity Factors Coefficient SE T P-value 95% CI
UL LL
Publication Year Dominant model 0.035 0.041 0.85 0.40 −0.048 1.119
Recessive model 0.140 0.036 3.81 0.07 −0.066 0.213
Allelic model 0.035 0.022 1.58 0.11 −0.009 0.080
TT vs. CC 0.123 0.064 1.91 0.06 −0.006 0.254
CT vs. CC 0.020 0.035 0.58 0.56 −0.050 0.090
continent Dominant model −0.238 0.265 −0.90 0.37 −0.772 0.294
Recessive model 0.022 0.274 0.08 0.93 −0.530 0.574
Allelic model −0.116 0.146 −0.79 0.43 −0.410 0.177
AA vs. CC −0.096 0.435 −0.22 0.82 −0.973 0.780
CA vs. CC −0.265 0.209 −1.27 0.21 −0.685 0.154
Genotyping methods Dominant model −0.137 0.241 −0.57 0.57 −0.621 0.346
Recessive model 0.382 0.232 1.65 0.10 −0.084 0.849
Allelic model 0.039 0.130 0.30 0.76 −0.221 0.300
TT vs. CC 0.056 0.388 0.14 0.88 −0.726 0.838
CT vs. CC −0.114 0.199 −0.57 0.57 −0.515 0.287
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IL-13 promote the harmful inflammatory events in the
airways. Studies have reported that local administration
of IL-4 gene plasmids prior to antigen challenge could
stimulate the airway hyperresponsiveness and accumula-
tion of eosinophils in mice [77]. This phenotype of
asthma is commonly referred to “eosinophilic” asthma.
On the other side, “noneosinophilic” asthma is charac-
terized by low frequency of eosinophils in the involved
sites, but other inflammatory cells are dominant in the
effector phase, such as neutrophils, mixed granulocyte
inflammatory cells, or even little number of inflamma-
tory cells, called paucigranulocytic inflammation. Th17
mediated IL-17 axis and lack of significant Th2/Th17 in-
flammation have been attributed to the noneosinophilic
asthma [78]. Among the SNPs in the IL4 gene, the
-589C/T (rs2243250) polymorphism has been widely in-
vestigated in susceptibility to asthma. It has been shown
that the T allele of this SNP leads to increased affinity of
the binding of transcription factors in comparison to the
C allele, leading to overexpression of IL4 mRNA [79,
80]. As a consequence, it is a biological justification that
IL4 gene −589C/T SNP impresses the IL-4 expression
and, hence, could affect the asthma susceptibility.
Previously, three meta-analysis studies have attempted
to disclose the association of IL4 gene −589C/T SNP
with the risk of asthma. Wang et al. in 2012 indicated
that the T allele of IL4 gene −589C/T SNP increased the
risk of asthma (OR = 1.12). Basically, individuals carrying
the T allele had a 24% increased risk of asthma in com-
parison to the CC homozygote model. Subgroup analysis
revealed the association of this polymorphism in the
Caucasians [81]. In addition, Nie et al. in 2013 included
40 studies involving 7345 cases and 7819 controls in
their meta-analysis [18]. This meta-analysis indicated
that TT vs. CC (OR = 1.40) and CT vs. CC (OR = 1.22)
models were significantly associated with increased risk
of asthma. In the subgroup analysis by ethnicity, signifi-
cant associations were found among Asians and Cauca-
sians, but not in the African-Americans. In addition, the
subgroup analysis by atopic status revealed no significant
association among atopic asthma patients and non-
atopic asthma patients. On the other side, Zhang et al.
Fig. 5 Meta-regression plots of the association between IL-4 C589T polymorphism and risk of asthma based on; a Continent (dominant), b
Genotyping methods (recessive), c Publication year (Allelic)
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Fig. 7 Sensitivity analysis in present meta-analysis investigates the single nucleotide polymorphisms of IL-4 C589T contribute to risk for asthma
Fig. 6 Begg’s funnel plot for publication bias test. Dominant model C598T. Each point represents a separate study for the indicated association
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[75] by evaluating pediatric asthma risk by evolving 17
case-control studies (15 publications) containing 3427
cases and 4247 controls revealed that IL4 -589C/T poly-
morphism was associated with increased risk of asthma
in pediatrics. Furthermore, the subgroup analyses by eth-
nicity, indicated significant association in Caucasians
and Asians.
Our analysis was performed on 55 case-control studies
containing 9572 cases and 9881 controls. It was ob-
served that IL4 gene -589C/T polymorphism increased
the risk of asthma across all genetic models, including
dominant model (OR = 1.22), recessive model (OR =
1.17), allelic model (OR = 1.21), and TT vs. CC model
(OR = 1.34), but not the CT vs. TT model. Furthermore,
subgroup analysis by age indicated that IL4 gene -589C/
T polymorphism was significantly associated with
asthma risk in both pediatrics and adults. The subgroup
analysis by ethnicity revealed significant association in
Asian, American, and Europeans. Finally, subgroup ana-
lysis by East Asian and non-East Asian populations indi-
cated significant associations.
This meta-analysis bears some limitations and caveats.
First, the analysis was according to crude estimation of
IL4 gene -589C/T polymorphism association with
asthma susceptibility, regardless of the effect of con-
founding factors, like age, sex, environmental factors,
and contribution of other genes in LD with IL4 gene.
Second, we did not analyze other genes that could be
contributing in understanding of cytokine involvement
in the susceptibility to asthma.
Conclusion
All in all, here we carried out the most up-to-date ana-
lysis of the IL4 gene 589C/T polymorphism and asthma
risk prior to September 2020. Our meta-analysis further
confirmed some results of the previously performed
meta-analysis, while rejected some of them. In a whole,
IL4 gene -589C/T polymorphism increased the risk of
asthma across all genetic models. Moreover, the sub-
group analysis by age indicated that IL4 gene -589C/T
polymorphism was significantly associated with asthma
risk in both pediatrics and adults. Also, the subgroup
analysis by ethnicity revealed significant association in
Asian, American, and Europeans. Ultimately, subgroup
analysis by East Asian and non-East Asian populations
indicated significant associations.
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